Kohei Omatsu Selected Research

Kohei Omatsu Research Topics

15	Neoplasms (Cancer) 10/2022 - 11/2013
10	Carcinoma (Carcinomatosis) 10/2023 - 05/2012
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2022 - 11/2010
7	Endometrial Neoplasms (Endometrial Cancer) 05/2022 - 05/2008
7	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 05/2012
6	Carcinosarcoma 09/2018 - 01/2017
5	Sarcoma (Soft Tissue Sarcoma) 10/2022 - 01/2017
5	Neoplasm Metastasis (Metastasis) 07/2020 - 11/2010
2	Lymphatic Metastasis 09/2022 - 09/2017
2	Anastomotic Leak 03/2021 - 01/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2018 - 02/2015
2	Pre-Eclampsia (Preeclampsia) 06/2005 - 06/2005
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Myoma 10/2022
1	Colorectal Neoplasms (Colorectal Cancer) 05/2022
1	Uterine Neoplasms (Uterine Cancer) 01/2022
1	Endometrial Hyperplasia 01/2022
1	Internal Hernia 01/2021
1	Disease Progression 09/2020
1	Pneumoperitoneum 11/2019
1	Wounds and Injuries (Trauma) 11/2019
1	Margins of Excision 01/2019
1	Endometrioid Carcinoma 03/2018
1	Menstruation Disturbances 03/2018
1	Adenomyoma 03/2018
1	Oral Leukoplakia 02/2018
1	Adenocarcinoma 09/2017
1	Vaginal Diseases 02/2015
1	Clear Cell Adenocarcinoma 02/2015
1	Proteinuria 06/2005
1	Thrombophilia 06/2005

6	PlatinumIBA 01/2018 - 11/2010
3	Hormones (Hormone)IBA 07/2020 - 03/2018
2	Progestins (Progestagens)IBA 01/2022 - 03/2018
1	Docetaxel (Taxotere)FDA Link 10/2023
1	Carboplatin (JM8)FDA LinkGeneric 10/2023
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 09/2022
1	Proteins (Proteins, Gene)FDA Link 05/2022
1	Bevacizumab (Avastin)FDA Link 09/2020
1	Progesterone FDA LinkGeneric 07/2020
1	ElementsIBA 09/2018
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 03/2018
1	1-dodecylpyridoxal (PLD)IBA 02/2018
1	liposomal doxorubicin (Doxil)FDA Link 02/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	rucaparibIBA 01/2018
1	taxaneIBA 12/2017
1	AntigensIBA 09/2017
1	Tamoxifen FDA LinkGeneric 02/2017
1	Diethylstilbestrol (Stilbestrol)FDA Link 02/2015
1	sparfosic acid (PALA)IBA 01/2015
1	Indicators and Reagents (Reagents)IBA 11/2013
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2010
1	Thrombin FDA Link 06/2005
1	FibrinIBA 06/2005
1	Phosphatidylcholines (Phosphatidylcholine)IBA 06/2005
1	PhosphatidylserinesIBA 06/2005
1	AntithrombinsIBA 06/2005
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2005
1	antithrombin III-protease complexIBA 06/2005

14	Drug Therapy (Chemotherapy) 01/2022 - 11/2010
9	Hysterectomy 10/2023 - 11/2010
9	Radiotherapy 01/2021 - 11/2010
8	Therapeutics 10/2023 - 01/2017
5	Adjuvant Chemotherapy 10/2023 - 05/2008
5	Lymph Node Excision (Lymph Node Dissection) 09/2022 - 01/2015
4	Neoadjuvant Therapy 03/2018 - 11/2010
3	Salpingo-oophorectomy 05/2022 - 09/2017
3	Pelvic Exenteration 01/2021 - 01/2018
2	Morcellation 10/2022 - 11/2019
2	Cytoreduction Surgical Procedures 03/2021 - 09/2017
2	Brachytherapy 07/2020 - 04/2015
2	Aftercare (After-Treatment) 03/2018 - 02/2015
2	Chemoradiotherapy 09/2017 - 02/2015
1	Overlapping Surgery 01/2023
1	Uterine Myomectomy 10/2022
1	Conservative Treatment 01/2022
1	Trachelectomy 09/2021
1	Length of Stay 03/2021
1	Cesarean Section (Caesarean Section) 07/2020
1	Oral Diagnosis (Oral Examination) 02/2018
1	Ileostomy 01/2018
1	Nephroureterectomy 09/2017